Swallowing function following postchemoradiotherapy neck dissection: Review of findings and analysis of contributing factors

Otolaryngology - Head and Neck Surgery

Volumn 145, Issue 3, 2011, Pages 428-434

  Chapuy, Claudia I ^a   Annino, Donald J ^b   Snavely, Anna ^a   Li, Yi ^a   Tishler, Roy B ^b   Norris, Charles M ^b   Haddad, Robert I ^a   Goguen, Laura A ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chemoradiation; Dysphagia; Head and neck cancer; Neck dissection

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASPIRATION; CANCER STAGING; CHEMORADIOTHERAPY; DIET; DISEASE ASSOCIATION; DYSPHAGIA; ESOPHAGUS STENOSIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NECK DISSECTION; OUTCOME ASSESSMENT; RADIATION DOSE; RETROSPECTIVE STUDY; STOMACH TUBE; SWALLOWING; TERTIARY HEALTH CARE; WEIGHT REDUCTION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; COHORT ANALYSIS; CONVALESCENCE; FOLLOW UP; GASTROSTOMY; HEAD AND NECK TUMOR; HOSPITALIZATION; HYPOPHARYNX TUMOR; LARYNX TUMOR; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OROPHARYNX TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DEGLUTITION; DEGLUTITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; GASTROSTOMY; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NECK DISSECTION; NEOADJUVANT THERAPY; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, ADJUVANT; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80055079635     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811403075     Document Type: Article

References (30)

1. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705-1715. (Pubitemid 350005152)
2. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949-955. (Pubitemid 30148259)
3. Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:772-778. (Pubitemid 40247972)
4. Goguen LA, Posner MR, Norris CM, et al. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg. 2006;134:916-922. (Pubitemid 43766551)
5. Caudell JJ, Schaner PE, Meredith RF, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;73:410-415.
6. Graner DE, Foote RL, Kasperbauer JL, et al. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope. 2003;113:573-579. (Pubitemid 36292890)
7. Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol. 2006;24:2636-2643. (Pubitemid 46622085)
8. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002;53:23-28. (Pubitemid 34465803)
9. Salama JK, Stenson KM, List MA, et al. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008;134:1060-1065.
10. Caglar HB, Tishler RB, Othus M, et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:1110-1118.
11. Ronis DL, Duffy SA, Fowler KE, et al. Changes in quality of life over 1 year in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008;134:241-248. (Pubitemid 351439249)
12. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582-3589.
13. Lango MN, Egleston B, Ende K, et al. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck. 2010;32:341-347.
14. Rosenbek JC, Robbins JA, Roecker EB, et al. A penetration-aspiration scale. Dysphagia. 1996;11:93-98. (Pubitemid 26107509)
15. Goguen LA, Posner MR, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:526-531. (Pubitemid 43742571)
16. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:1418-1423. (Pubitemid 38438302)
17. Nouraei SA, Upile T, Al-Yaghchi C, et al. Role of planned postchemoradiotherapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope. 2008;118:797-803. (Pubitemid 351631295)
18. Goguen LA, Chapuy CI, Sher DJ, et al. Utilizing computed tomography as road map for designing selective and superselective neck dissection after chemoradiotherapy. Otolaryngol Head Neck Surg. 2010;143:367-374.
19. Davidson BJ, Newkirk KA, Harter KW, et al. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg. 1999;125:401-405. (Pubitemid 29169766)
20. Goguen LA, Chapuy CI, Li Y, Zhao SD, Annino DJ. Neck dissection after chemoradiotherapy: timing and complications. Arch Otolaryngol Head Neck Surg. 2010;136:1071-1077.
21. Lazarus C, Logemann JA, Pauloski BR, et al. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck. 2007;29:632-637. (Pubitemid 47168233)
22. Rademaker AW, Vonesh EF, Logemann JA, et al. Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout. Head Neck. 2003;25:1034-1041. (Pubitemid 37475266)
23. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098. (Pubitemid 37464533)
24. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:1161-1171. (Pubitemid 32727792)
25. Ang KK, Harris J, Garden AS, et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol. 2005;23:3008-3015. (Pubitemid 46224121)
26. Citrin D, Mansueti J, Likhacheva A, et al. Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;74:1040-1046.
27. Lee WT, Akst LM, Adelstein DJ, et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck. 2006;28:808-812. (Pubitemid 44320534)
28. Lawson JD, Otto K, Grist W, et al. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol. 2008;29:13-19. (Pubitemid 350180153)
29. Nguyen NP, Frank C, Moltz CC, et al. Analysis of factors influencing aspiration risk following chemoradiation for oropharyngeal cancer. Br J Radiol. 2009;82:675-680.
30. Caudell JJ, Schaner PE, Desmond RA, et al. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2010;76:403-409.